Literature DB >> 23868894

The myotoxic effect of bupivacaine and ropivacaine on myotubes in primary mouse cell culture and an immortalized cell line.

Petra Hofmann1, Thomas Metterlein, Gabriele Bollwein, Michael Gruber, Christoph Plank, Bernhard M Graf, Wolfgang Zink.   

Abstract

BACKGROUND: The 2 local anesthetics (LAs) bupivacaine and ropivacaine have acute cytotoxic effects on different tissues. In this respect, LA-induced myotoxicity has been subject to various studies; however, the exact mechanisms are still not fully understood. Most in vitro studies use immortalized cell lines because of feasibility. Thus, establishing a primary cell line might result in more accurate results. In this study, we examined the effects of immortalization on bupivacaine- and ropivacaine-induced myotoxicity in vitro.
METHODS: An immortalized (N = 6) and a primary cell line (N = 8) of the same tissue and species were established, and differentiation in myotubes was induced. Cells were exposed to increasing concentrations of bupivacaine and ropivacaine for 1 or 2 hours, respectively. Twenty-four and 48 hours after treatment, the fractions of dead and vital cells were measured using flow cytometry. Significance was tested through 1-way analysis of variance with post hoc Dunnett T3 test. Medians of dataset pairs were compared by T test.
RESULTS: In both cell lines, increasing concentrations of both LAs resulted in decreased cell survival (e.g., P < 0.001 for 5000 ppm bupivacaine, 1 or 2 hours of incubation, and 24 hours recovery in both cell lines). For the same LA concentrations, survival was significantly higher in the immortalized cell culture (e.g., P < 0.001 for 2500 ppm ropivacaine, 1 hour of incubation, and 24 hours recovery). In addition, equal concentrations of bupivacaine resulted in significantly fewer vital cells compared with ropivacaine (e.g., P = 0.032 for 2500 ppm ropivacaine, 1 hour of incubation, and 24 hours recovery). Two hours of incubation resulted in a significantly higher rate of dead cells compared with 1 hour of incubation (e.g., P = 0.004 for C2C12 cells, 2500 ppm bupivacaine, and 24 hours recovery).
CONCLUSIONS: Primary skeletal muscle cells are more vulnerable to LAs than immortalized cells. The higher myotoxic potential of bupivacaine compared with ropivacaine in vivo can be reproduced in vitro. Incubation time has an influence on cell survival.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23868894     DOI: 10.1213/ANE.0b013e31829e4197

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  8 in total

1.  Delivery of local anaesthetics by a self-assembled supramolecular system mimicking their interactions with a sodium channel.

Authors:  Tianjiao Ji; Yang Li; Xiaoran Deng; Alina Y Rwei; Abraham Offen; Sherwood Hall; Wei Zhang; Chao Zhao; Manisha Mehta; Daniel S Kohane
Journal:  Nat Biomed Eng       Date:  2021-09-13       Impact factor: 25.671

2.  Myotoxicity of local anesthetics is equivalent in individuals with and without predisposition to malignant hyperthermia.

Authors:  Sachiko Otsuki; Toshimichi Yasuda; Keiko Mukaida; Yuko Noda; Rieko Kanzaki; Hirotsugu Miyoshi; Takashi Kondo; Hiroshi Hamada; Masashi Kawamoto
Journal:  J Anesth       Date:  2018-06-25       Impact factor: 2.078

3.  Lidocaine Inhibits Myoblast Cell Migration and Myogenic Differentiation Through Activation of the Notch Pathway.

Authors:  Xiangtian Ling; Xinqi Ma; Xielan Kuang; Yuxiu Zou; Han Zhang; Han Tang; Han Du; Binbin Zhu; Hao Huang; Qing Xia; Minghao Chen; Danyi Mao; Dongli Chen; Huangxuan Shen; Jianhua Yan
Journal:  Drug Des Devel Ther       Date:  2021-03-02       Impact factor: 4.162

4.  Potential Impact of Local Anesthetics Inducing Granulocyte Arrest and Altering Immune Functions on Perioperative Outcome.

Authors:  Gesche Kolle; Thomas Metterlein; Michael Gruber; Timo Seyfried; Walter Petermichl; Sophie-Marie Pfaehler; Diane Bitzinger; Sigrid Wittmann; Andre Bredthauer
Journal:  J Inflamm Res       Date:  2021-01-06

Review 5.  Comparison of in vitro and in vivo Toxicity of Bupivacaine in Musculoskeletal Applications.

Authors:  Jasper G Steverink; Susanna Piluso; Jos Malda; Jorrit-Jan Verlaan
Journal:  Front Pain Res (Lausanne)       Date:  2021-08-20

6.  In vitro myotoxic effects of bupivacaine on rhabdomyosarcoma cells, immortalized and primary muscle cells.

Authors:  Thomas Metterlein; Petra Hoffmann; Ruth Späth; Michael Gruber; Bernhard M Graf; Wolfgang Zink
Journal:  Cancer Cell Int       Date:  2015-07-29       Impact factor: 5.722

7.  Increased sodium channel use-dependent inhibition by a new potent analogue of tocainide greatly enhances in vivo antimyotonic activity.

Authors:  Michela De Bellis; Roberta Carbonara; Julien Roussel; Alessandro Farinato; Ada Massari; Sabata Pierno; Marilena Muraglia; Filomena Corbo; Carlo Franchini; Maria Rosaria Carratù; Annamaria De Luca; Diana Conte Camerino; Jean-François Desaphy
Journal:  Neuropharmacology       Date:  2016-10-13       Impact factor: 5.250

8.  Dual Action of Mexiletine and Its Pyrroline Derivatives as Skeletal Muscle Sodium Channel Blockers and Anti-oxidant Compounds: Toward Novel Therapeutic Potential.

Authors:  Michela De Bellis; Francesca Sanarica; Alessia Carocci; Giovanni Lentini; Sabata Pierno; Jean-François Rolland; Diana Conte Camerino; Annamaria De Luca
Journal:  Front Pharmacol       Date:  2018-01-12       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.